Immune Therapeutics Inc (IMUND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMUND | ZVSA | BDRX | ||
| Company | Immune Therapeutics Inc | Zyversa Therapeutics Inc | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 5.5000 | 1.1400 | 4.30 | ||
| High | 5.7500 | 1.1784 | 7.47 | ||
| Low | 5.2500 | 1.1100 | 4.18 | ||
| Last | 5.2500 | 1.1400 | 4.40 | ||
| Change | -0.4900 | -0.0100 | +0.55 | ||
| % Change | -8.54% | -0.87% | +14.29% | ||
| Volume | 500 | 244,800 | 5,816,800 | ||
| 20-Day Average Volume | 1,820 | 3,573,890 | 333,365 | ||
| Previous Close | 5.7400 | 1.1500 | 3.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.7010 | 1.5881 | 5.23 | ||
| 20-Day Raw Stochastic | 15.76% | 4.29% | 22.67% | ||
| 20-Day Relative Strength | 35.24% | 33.50% | 38.60% | ||
| Weighted Alpha | -80.14 | -92.74 | -93.07 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.23% since 05/26/21 | +0.88% since 11/14/24 | -9.47% since 11/14/24 | ||
| Low | 5.2500 on 06/03/21 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 6.0000 on 05/28/21 | 1.2899 on 11/19/24 | 7.47 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -62.77% since 05/03/21 | -50.43% since 10/21/24 | -26.42% since 10/21/24 | ||
| Low | 2.5000 on 05/10/21 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 19.9500 on 05/11/21 | 3.3700 on 11/05/24 | 7.47 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | -72.37% since 03/03/21 | -69.52% since 08/21/24 | -72.50% since 08/21/24 | ||
| Low | 2.5000 on 05/10/21 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 26.0000 on 03/10/21 | 3.9600 on 08/22/24 | 16.00 on 08/26/24 | ||
| 6-Month | |||||
| %Chg | -65.46% since 12/03/20 | -74.09% since 05/21/24 | -92.45% since 05/21/24 | ||
| Low | 2.5000 on 05/10/21 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 32.7000 on 02/22/21 | 6.3000 on 07/10/24 | 42.50 on 05/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3 | 1,185 | 458 | ||
| Shares Outstanding, K | 0 | 1,030 | 119 | ||
| Annual Sales | 0 | 0 | 410,000 | ||
| Annual Net Income | 1,590,000 | -98,300,000 | -7,660,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | 790,000 | -2,400,000 | N/A | ||
| 60-Month Beta | 0.94 | 0.65 | 1.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -2.43 on 11/14/24 | N/A | ||
| Latest Earnings Date | 07/05/21 | 11/12/24 | 04/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||